Moderna, Inc. (MRNA) vs Waters Corporation (WAT)

A side-by-side comparison of Moderna, Inc. and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnMRNA vs WAT

growth of $100 · dividends reinvested · last 8y
MRNA +193.0%WAT +86.5%MRNA compounded faster
05001k2k2k3kStart $1002020202220242026$293$186
MRNA WAT

MRNA vs WAT: by the numbers

  • WAT is the larger company ($24.68B vs $22.45B market cap).
  • WAT is profitable (11.91% net margin) while MRNA runs a net loss (-143.55%).
  • MRNA grew revenue faster over the past five years (19.33% vs 8.48% CAGR).

Metrics side by side

Valuation

MetricMRNAWAT
P/E ratioN/A48.22
Forward P/EN/A26.13
P/S ratio9.678.27
P/B ratio2.912.04
PEG ratioN/A75.61
EV / EBITDAN/A38.08
FCF yieldN/A0.85%

Profitability

MetricMRNAWAT
Gross margin55.35%55.02%
Operating margin-153.35%28.22%
Net margin-143.55%11.91%
ROE-43.12%2.94%
ROIC-29.70%17.57%

Growth (annualized)

MetricMRNAWAT
Revenue CAGR (5Y)19.33%8.48%
EPS CAGR (5Y)N/A5.16%
FCF CAGR (5Y)N/A-17.63%
Total return CAGR (5Y)-30.89%-0.60%

Frequently asked

Which has grown faster, MRNA or WAT?
Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus WAT at 8.48%.
Is MRNA or WAT more profitable?
WAT runs the higher net margin — MRNA at -143.55% versus WAT at 11.91%.
How have MRNA and WAT total returns compared?
Over the past 5 years, MRNA delivered -30.89% and WAT delivered 9.09% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.